The U.S. Food and Drug Administration (FDA) is interested in the development of resources to reduce the use of opioids where alternatives exist, so ACEP shared its extensive opioid resources. To view those resources, click here. Our two opioid-related point-of-care tools—MAP (managing acute pain) and BUPE (buprenorphine)—are now available on our new app, emPOC, available through the Apple Store and Google Play.
ACEP Shares Opioid Resources with FDA
Topics: emPOC appFDAOpioid CrisisOpioidsPoint-of-CareTechnology
Related
-
E-QUAL 2021 Enrollment Open for Opioid, Stroke Collaboratives
January 22, 2021 - 0 Comment -
ACEP Continues Multi-Front Efforts in Opioid Battle
November 18, 2020 - 0 Comment -
By the Numbers: X-Waiver
October 28, 2020 - 0 Comment
No Responses to “ACEP Shares Opioid Resources with FDA”